Jupiter Research Capital (Asia) Ltd’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$398K Buy
+12,728
New +$597K 0.04% 402

Other funds holding GPCR

Jupiter Research Capital (Asia) Ltd's GPCR Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Structure Therapeutics (GPCR) in Q3 2026: 12,728 shares worth $398K. The stake represents 0.04% of the portfolio and ranks #402 among its holdings.

163 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 12,728 shares of Structure Therapeutics worth $398K as of Q3 2026.
  • Structure Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Structure Therapeutics made up 0.04% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #402 holding.
  • 163 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.